Epidemiological, Clinical and Laboratory Characteristics of Patients with Brucella Infection in Anhui Province, China

References

• Liang C, Wei W, Liang X, De E, Zheng B. Spinal brucellosis in Hulunbuir, China, 2011–2016. Infect Drug Resist. 2019;12:1565–1571. doi:10.2147/IDR.S20244031239732
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu X, Duan K, Peng Q. Research progress on brucellosis. Curr Med Chem. 2019;26(30):5598–5608. doi:10.2174/092986732566618051012500929745323
   PubMed Web of Science ®Google Scholar
• Ye HY, Xing FF, Yang J, et al. High index of suspicion for brucellosis in a highly cosmopolitan city in southern China. Bmc Infect Dis. 2020;20(1):22. doi:10.1186/s12879-019-4748-y31914937
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li J, Ma L, et al. Molecular characteristics of Brucella melitensis isolates from humans in Qinghai Province, China. Infect Dis Poverty. 2021;10(1). doi:10.1186/s40249-021-00829-0.
   Web of Science ®Google Scholar
• Jiang W, Chen J, Li Q, et al. Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China. Bmc Infect Dis. 2019;19(1):439. doi:10.1186/s12879-019-4081-531109292
   PubMed Web of Science ®Google Scholar
• Lai S, Zhou H, Xiong W, et al. Changing epidemiology of human brucellosis, China, 1955–2014. Emerg Infect Dis. 2017;23(2):184–194. doi:10.3201/eid2302.15171028098531
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang H, Liu X, et al. Increasing threat of brucellosis to low-risk persons in urban settings, China. Emerg Infect Dis. 2014;20(1):126–130. doi:10.3201/eid2001.13032424377827
   PubMed Web of Science ®Google Scholar
• Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91–99. doi:10.1016/S1473-3099(06)70382-616439329
   PubMed Web of Science ®Google Scholar
• Wang H, Xu WM, Zhu KJ, et al. Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China. Emerg Microbes Infect. 2020;9(1):889–899.32284015
   PubMed Web of Science ®Google Scholar
• Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7(12):775–786. doi:10.1016/S1473-3099(07)70286-418045560
   PubMed Web of Science ®Google Scholar
• Shi Y, Gao H, Pappas G, et al. Clinical features of 2041 human brucellosis cases in China. PLoS One. 2018;13(11):e205500. doi:10.1371/journal.pone.0205500
   Web of Science ®Google Scholar
• Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36(Suppl 1):S12–S17. doi:10.1016/j.ijantimicag.2010.06.01420692128
   PubMed Web of Science ®Google Scholar
• Pappas G, Papadimitriou P. Challenges in Brucella bacteraemia. Int J Antimicrob Agents. 2007;30(Suppl 1):S29–S31. doi:10.1016/j.ijantimicag.2007.06.01117706402
   PubMed Web of Science ®Google Scholar
• Memish Z, Mah MW, Mahmoud SA, Shaalan MA, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect. 2000;40(1):59–63. doi:10.1053/jinf.1999.058610762113
   PubMed Web of Science ®Google Scholar
• Kadanali A, Ozden K, Altoparlak U, Erturk A, Parlak M, Kadanali A. Bacteremic and nonbacteremic brucellosis: clinical and laboratory observations. Infection. 2009;37(1):67–69. doi:10.1007/s15010-008-7353-319139815
   PubMed Web of Science ®Google Scholar
• Qie C, Cui J, Liu Y, Li Y, Wu H, Mi Y. Epidemiological and clinical characteristics of bacteremic brucellosis. J Int Med Res. 2020;48(7):1410563826. doi:10.1177/0300060520936829
   Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Diagnosis for Brucellosis (WS 269—2019). Beijing: National Health Commission of the People’s Republic of China; 2019.
   Google Scholar
• Xu N, Dong X, Yao Y, et al. Improved early detection of focal brucellosis complications with anti-Brucella IgG. J Clin Microbiol. 2020;58(10):10. doi:10.1128/JCM.00903-20
   Web of Science ®Google Scholar
• Deqiu S, Donglou X, Jiming Y. Epidemiology and control of brucellosis in China. Vet Microbiol. 2002;90(1–4):165–182. doi:10.1016/S0378-1135(02)00252-312414142
   PubMed Web of Science ®Google Scholar
• Kong W. Brucellosis infection increasing in Southern China. Eur J Intern Med. 2018;51:e16–e18. doi:10.1016/j.ejim.2018.03.00429549979
   PubMed Web of Science ®Google Scholar
• Jiang H, O’Callaghan D, Ding J-B. Brucellosis in China: history, progress and challenge. Infect Dis Poverty. 2020;9(1):55. doi:10.1186/s40249-020-00673-832448394
   PubMed Web of Science ®Google Scholar
• Zheng R, Xie S, Lu X, et al. A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. Biomed Res Int. 2018;2018:5712920. doi:10.1155/2018/571292029850535
   PubMed Web of Science ®Google Scholar
• Yuan HT, Wang CL, Liu LN, et al. Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in hinggan league of the inner mongolia autonomous region, China. Infect Dis Poverty. 2020;9(1):79. doi:10.1186/s40249-020-00697-032600403
   PubMed Web of Science ®Google Scholar
• Dokuzoğuz B, Ergönül O, Baykam N, et al. Characteristics of B. melitensis versus B. abortus bacteraemias. J Infect. 2005;50(1):41–45. doi:10.1016/j.jinf.2004.02.00515603839
   PubMed Web of Science ®Google Scholar
• Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33(1). doi:10.1128/CMR.00073-19
   PubMed Web of Science ®Google Scholar
• Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352(22):2325–2336. doi:10.1056/NEJMra05057015930423
   PubMed Web of Science ®Google Scholar
• Apa H, Devrim I, Memur S, et al. Factors affecting Brucella spp. blood cultures positivity in children. Vector Borne Zoonotic Dis. 2013;13(3):176–180. doi:10.1089/vbz.2012.099723421883
   PubMed Web of Science ®Google Scholar
• Ariza J, Pigrau C, Cañas C, et al. Current understanding and management of chronic hepatosplenic suppurative brucellosis. Clin Infect Dis. 2001;32(7):1024–1033. doi:10.1086/31960811264030
   PubMed Web of Science ®Google Scholar
• Ozturk-Engin D, Erdem H, Gencer S, et al. Liver involvement in patients with brucellosis: results of the Marmara study. Eur J Clin Microbiol Infect Dis. 2014;33(7):1253–1262. doi:10.1007/s10096-014-2064-424557334
   PubMed Web of Science ®Google Scholar
• Jia B, Zhang F, Lu Y, et al. The clinical features of 590 patients with brucellosis in Xinjiang, China with the emphasis on the treatment of complications. PLoS Negl Trop Dis. 2017;11(5):e5577. doi:10.1371/journal.pntd.0005577
   Web of Science ®Google Scholar
• Yoldas T, Tezer H, Ozkaya-Parlakay A, Sayli TR. Clinical and laboratory findings of 97 pediatric brucellosis patients in central Turkey. J Microbiol Immunol Infect. 2015;48(4):446–449. doi:10.1016/j.jmii.2014.04.01625092047
   PubMedGoogle Scholar
• Patra S, Tellapragada C, Mukhopadhyay C. Human brucellosis: experience from a tertiary care hospital in southern India. Trop Doct. 2018;48(4):368–372. doi:10.1177/004947551878846730149785
   PubMed Web of Science ®Google Scholar
• Grasso E, Conversa P, Mondino P, Spirolazzi MP, Dalmasso G, Raineri G. [295 cases of brucellosis treated with minocycline]. Minerva Med. 1987;78(19):1443–1447. [ Norwegian]3670688
   PubMedGoogle Scholar
• Ranjbar M, Keramat F, Mamani M, et al. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis. 2007;11(2):152–156. doi:10.1016/j.ijid.2005.11.00716798042
   PubMed Web of Science ®Google Scholar